Director Increases Stake in Ondine
Non-executive Director Margaret Shaw purchased 30,000 shares at 12 pence per share.
- Shares purchased by Margaret Shaw 30,000
- Purchase price per share 12 pence
- Margaret Shaw's total holding after purchase 243,853 shares
- Margaret Shaw's shareholding percentage 0.0552%
Select text to share a quote on X · sign in to keep highlights & notes in your OBI notes
Ondine Biomedical Inc. (AIM: OBI), a Canadian life sciences company pioneering light-activated antimicrobial treatments, announces that Margaret Shaw, Non-executive Director, has bought 30,000 shares ("Common Shares") in the Company at a price of 12 pence per Common Share on 29 January 2025.
Following this transaction, Margaret Shaw holds 243,853 Common Shares representing 0.0552% of the issued share capital of the Company.
About Ondine Biomedical Inc.
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Margaret Shaw |
| 2. | Reason for the Notification | |
| a) | Position/status | Non-executive Director (PDMR) |
| b) | Initial notification/Amendment | Initial notification |
| a) | Name | Ondine Biomedical Inc. |
| b) | LEI | 213800QO681575J97813 |
| a) | Description of the Financial instrument, type of instrument | Common shares |
| Identification code | ISIN: CA68234M2058 | |
| b) | Nature of the transaction | Share purchase |
| c) | Price(s) and volume(s) | 30,000 shares at 12 pence each |
| d) | Aggregated information: ·Aggregated volume ·Price | N/A |
| e) | Date of the transaction | 29 January 2025 |
| f) | Place of the transaction | AIM |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.